Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Tumor - Metastatic
Interventions: DRUG: Cabozantinib|DRUG: Trastuzumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Exelixis|Genentech, Inc.